Page 2 - Broadcast Date News Today

In this webinar, two experts in 3D cell culture and organoid biology, Dr. Elizabeth Abraham (Corning Life Sciences) and Dr. Lauretta Lacko (Weill Cornell Medicine), will share their expertise on this exciting field.

This webinar will explore several strategies for extending sample stability, alternatives to whole blood samples in flow cytometry, and their successful implementations in clinical studies.

On this episode of GEN Live, John Cumbers, PhD, CEO of SynBioBeta and Shelby Newsad, PhD, Investor at the Venture Capital firm Compound, join us for a broad discussion on the state of synbio—where the field is now and where it’s heading.

In this GEN webinar, we will hear how our distinguished guest, Dr. David Öling, and his team set out to optimize DNA construct development, fully aware that if they cracked the code on accelerating this step, it would affect all downstream processes and speed up early drug discovery.

In this GEN webinar, our distinguished speaker Dr. Nicholas Valiante, will provide insights into designing, developing, and manufacturing mRNA vaccines to maximize performance. Dr. Valiante will expand on the process to evaluate and select ionizable lipids required for mRNA-LNP vaccines development.

In this GEN webinar, our distinguished guests, Dr. Agne Antanaviciute and Stefan Zaharievski, will describe how a novel alternative to traditional cell sorting and labeling—LeviCell—can be used to improve significantly single-cell data quality and cell recoveries in complex clinical tissue samples.

Join us for this GEN webinar, where scientists from Codexis and Tune Therapeutics will highlight how engineered enzymes overcome common challenges with capping efficiency and dsRNA impurities in IVT manufacturing of mRNA required for vaccines and cell/gene therapeutics.

Join us for this GEN webinar on the latest gene writing and gene rewriting advancements.

Join us for this GEN webinar, where our distinguished guests, Dr. Tommy Duncan and Dr. Jill Makin, will provide an insightful discussion on how doggybone DNA (dbDNA), an enzymatically produced alternative to pDNA, can offer a rapid pathway to GMP, alongside a scalable, and safe solution to support a wide range of genetic medicines.

In this GEN webinar, our distinguished guest, Dr. Guillaume Pfefer, CEO of Senda Biosciences, will share how to access the "chemical address code" from nature's interspecies cellular communication—and how his organization's machine learning-enabled platform is genuinely turning the crank to comprehensively program medicines for the very first time.